Table 1.
Criteria for diagnosis of the metabolic syndrome*
| Feature | Cutoffs |
|---|---|
| Elevated waist circumference | Population and country-specific definitions** |
| Elevated triglycerides or drug treatment for elevated triglycerides |
≥150 mg/dL (1.7 mmol/L) |
| Reduced high-density lipoprotein cholesterol (HDL-C) or drug treatment for reduced HDL-C |
< 40 mg/dL (1.0 mmol/L) in males < 50 mg/dL (1.3 mmol/L) in females |
| Hypertension (or antihypertensive drug therapy in patient with history of hypertension) |
Systolic ≥ 130 mm Hg and/or Diastolic ≥ 85 mm Hg |
| Elevated fasting glucose (or drug treatment for elevated glucose) |
≥ 100 mg/dL |
| Presence of 3 of the 5 criteria denote presence of metabolic syndrome | |
*
Adapted from Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640–164510.
**
For U.S.: ≥ 102cm for men, ≥ 88 cm for women. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998; 6(suppl 2):51S–209S.